BlackRock Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.01M | Buy |
318,291
+3,297
| +1% | +$10.4K | ﹤0.01% | 2682 |
|
|
2016
Q3 | $1.08M | Buy |
314,994
+48,758
| +18% | +$166K | ﹤0.01% | 2605 |
|
|
2016
Q2 | $608K | Buy |
266,236
+49,312
| +23% | +$113K | ﹤0.01% | 2940 |
|
|
2016
Q1 | $545K | Sell |
216,924
-12,117
| -5% | -$30.4K | ﹤0.01% | 2856 |
|
|
2015
Q4 | $758K | Buy |
229,041
+3,427
| +2% | +$11.3K | ﹤0.01% | 2777 |
|
|
2015
Q3 | $546K | Sell |
225,614
-7,509
| -3% | -$18.2K | ﹤0.01% | 2987 |
|
|
2015
Q2 | $683K | Buy |
233,123
+44,420
| +24% | +$130K | ﹤0.01% | 3003 |
|
|
2015
Q1 | $757K | Buy |
188,703
+1,214
| +0.6% | +$4.87K | ﹤0.01% | 2706 |
|
|
2014
Q4 | $564K | Hold |
187,489
| – | – | ﹤0.01% | 2940 |
|
|
2014
Q3 | $475K | Buy |
187,489
+4,616
| +3% | +$11.7K | ﹤0.01% | 2989 |
|
|
2014
Q2 | $450K | Buy |
182,873
+55,895
| +44% | +$138K | ﹤0.01% | 3080 |
|
|
2014
Q1 | $337K | Sell |
126,978
-501
| -0.4% | -$1.33K | ﹤0.01% | 3100 |
|
|
2013
Q4 | $370K | Sell |
127,479
-1,288
| -1% | -$3.74K | ﹤0.01% | 3080 |
|
|
2013
Q3 | $395K | Buy |
128,767
+10,076
| +8% | +$30.9K | ﹤0.01% | 3015 |
|
|
2013
Q2 | $379K | Buy |
+118,691
| New | +$379K | ﹤0.01% | 2991 |
|